Susan Altschuller serves as Executive at Cerevel Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Susan Altschuller has executed 5 insider transactions totaling $604.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 6, 2026 involved receiving (via award) 142,500 shares valued at $0.
Susan Altschuller currently holds 142,500 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Altschuller has been a net seller of CERE stock. They have purchased $32.1K and sold $571.9K worth of shares.
Susan Altschuller's most recent insider trade was on Jan 6, 2026, when they sold 142,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.21 |
| Discretionary |
| Aug 1, 2024 | CERE | $0 | Disposition | 16,913 | $N/A | Discretionary |
| Dec 20, 2023 | CERE | $571.9K | Sale | 13,808 | $41.42 | Discretionary |
| Dec 19, 2023 | CERE | $0 | Option Exercise | 30,721 | $N/A | Discretionary |